# Benin Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Benin HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Benin (BEN)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $167.5K
- Products: 26
- Buyer markets: 24
- Average CAGR: +11.3%
- Global sector size: $170.3B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $89.5B | $66.3K | $46.9B | +1.0% | 12 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $32.2B | $54.2K | $12.2B | -6.8% | 17 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $11.9B | $47.2 | $6.8B | +52.3% | 2 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $5.2B | $6.2K | $3.0B | +7.7% | 5 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $5.2B | $12.4K | $2.0B | +21.4% | 4 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $3.2B | $0.4 | $1.7B | +24.1% | 2 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $2.4B | $135.5 | $1.6B | -7.3% | 1 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $3.8B | $200.0 | $1.5B | +10.2% | 3 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $2.6B | $661.3 | $1.4B | +42.7% | 3 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $1.8B | $193.0 | $1.2B | -36.5% | 2 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $3.1B | $148.2 | $759.8M | +10.9% | 2 | +0.0% |
| HS 330590 - Hair preparations: n.e.s. in heading no. 3305 | $1.3B | $591.5 | $623.3M | +184.1% | 3 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $1.4B | $3.5K | $532.4M | -11.0% | 2 | +0.0% |
| HS 340111 - Soap and organic surface-active products: in the form of bars, cakes, moulded shapes, and paper, wadding, felt and nonwovens, impregnated, coated or covered with soap or detergent, for toilet use (including medicated products) | $1.0B | $19.9K | $525.3M | +4.5% | 3 | +0.0% |
| HS 381519 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with an active substance other than nickel or precious metals or their compounds, n.e.c. or included | $634.0M | $496.2 | $448.7M | -43.5% | 1 | +0.0% |
| HS 300213 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale | $479.8M | $52.1 | $338.0M | +47.1% | 1 | +0.0% |
| HS 330420 - Cosmetic and toilet preparations: eye make-up | $728.3M | $160.3 | $328.2M | -15.0% | 2 | +0.0% |
| HS 340600 - Candles, tapers and the like | $500.1M | $23.2 | $298.9M | +21.3% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $562.9M | $23.3 | $274.6M | -17.4% | 1 | +0.0% |
| HS 340290 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), including auxiliary washing preparations, not for retail sale | $769.7M | $517.6 | $271.6M | +0.3% | 2 | +0.0% |
| HS 330510 - Hair preparations: shampoos | $240.6M | $62.1 | $236.9M | +11.5% | 1 | +0.0% |
| HS 300190 - Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 | $585.2M | $366.7 | $230.2M | +46.2% | 1 | +0.0% |
| HS 340319 - Lubricating preparations: (other than for the treatment of textile and similar materials), containing less than 70% (by weight) of petroleum oils or oils obtained from bituminous minerals | $360.3M | $14.9 | $154.9M | +5.8% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $507.2M | $261.3 | $154.6M | -4.5% | 1 | +0.0% |
| HS 340130 - Organic surface-active products and preparations for washing the skin, in the form of liquid or cream and put up for retail sale, whether or not containing soap | $334.8M | $1.0K | $122.1M | +25.2% | 1 | +0.0% |
| HS 330112 - Oils, essential: of orange (terpeneless or not), including concretes and absolutes | $125.9M | $7.0 | $115.4M | -27.8% | 1 | +0.0% |

## Best markets

- Switzerland, Liechtenstein (CHE): $28.2B calculated opportunity across 3 products.
- Belgium (BEL): $14.4B calculated opportunity across 9 products.
- France (FRA): $13.0B calculated opportunity across 18 products.
- Canada (CAN): $6.2B calculated opportunity across 7 products.
- Germany (DEU): $4.4B calculated opportunity across 13 products.
- China (CHN): $4.1B calculated opportunity across 1 products.
- Ireland (IRL): $3.6B calculated opportunity across 3 products.
- Spain (ESP): $2.4B calculated opportunity across 3 products.
- USA, Puerto Rico and US Virgin Islands (USA): $1.9B calculated opportunity across 2 products.
- Netherlands (NLD): $986.5M calculated opportunity across 2 products.
- South Africa (ZAF): $677.5M calculated opportunity across 1 products.
- Italy (ITA): $593.9M calculated opportunity across 1 products.

## Growth stars

- HS 330590: +184.1% average CAGR, $623.3M calculated opportunity.
- HS 300215: +52.3% average CAGR, $6.8B calculated opportunity.
- HS 300213: +47.1% average CAGR, $338.0M calculated opportunity.
- HS 300190: +46.2% average CAGR, $230.2M calculated opportunity.
- HS 330290: +42.7% average CAGR, $1.4B calculated opportunity.
- HS 340130: +25.2% average CAGR, $122.1M calculated opportunity.
- HS 300214: +24.1% average CAGR, $1.7B calculated opportunity.
- HS 382200: +21.4% average CAGR, $2.0B calculated opportunity.
- HS 340600: +21.3% average CAGR, $298.9M calculated opportunity.
- HS 330510: +11.5% average CAGR, $236.9M calculated opportunity.

## Diversification opportunities

- HS 330499: 17 buyer markets, $12.2B calculated opportunity.
- HS 300490: 12 buyer markets, $46.9B calculated opportunity.
- HS 330300: 5 buyer markets, $3.0B calculated opportunity.
- HS 382200: 4 buyer markets, $2.0B calculated opportunity.
- HS 300212: 3 buyer markets, $1.5B calculated opportunity.
- HS 330290: 3 buyer markets, $1.4B calculated opportunity.
- HS 330590: 3 buyer markets, $623.3M calculated opportunity.
- HS 340111: 3 buyer markets, $525.3M calculated opportunity.
- HS 300215: 2 buyer markets, $6.8B calculated opportunity.
- HS 300214: 2 buyer markets, $1.7B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.